MA35887B1 - New morpholynyl derivatives useful as mogat-2 inhibitors - Google Patents

New morpholynyl derivatives useful as mogat-2 inhibitors

Info

Publication number
MA35887B1
MA35887B1 MA37245A MA37245A MA35887B1 MA 35887 B1 MA35887 B1 MA 35887B1 MA 37245 A MA37245 A MA 37245A MA 37245 A MA37245 A MA 37245A MA 35887 B1 MA35887 B1 MA 35887B1
Authority
MA
Morocco
Prior art keywords
mogat
morpholynyl
inhibitors
new
derivatives useful
Prior art date
Application number
MA37245A
Other languages
French (fr)
Inventor
Maria Carmen Fernandez
Maria Rosario Gonzalez-Garcia
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/022828 external-priority patent/WO2013116065A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MA35887B1 publication Critical patent/MA35887B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des composés de formule i ou leur sel pharmaceutiquement acceptable, des procédés de traitement de l'hypertriglycéridémie à l'aide desdits composés, et un procédé de préparation desdits composés.The present invention relates to compounds of formula I or their pharmaceutically acceptable salt, methods of treating hypertriglyceridemia using said compounds, and a process for preparing said compounds.

MA37245A 2012-01-31 2014-07-24 New morpholynyl derivatives useful as mogat-2 inhibitors MA35887B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12382037 2012-01-31
PCT/US2013/022828 WO2013116065A1 (en) 2012-01-31 2013-01-24 Novel morpholinyl derivatives useful as mogat-2 inhibitors

Publications (1)

Publication Number Publication Date
MA35887B1 true MA35887B1 (en) 2014-12-01

Family

ID=53171644

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37245A MA35887B1 (en) 2012-01-31 2014-07-24 New morpholynyl derivatives useful as mogat-2 inhibitors

Country Status (1)

Country Link
MA (1) MA35887B1 (en)

Similar Documents

Publication Publication Date Title
MA41134A (en) 5-AMINO-6H-THIAZOLO [4,5-D] PYRIMIDINE-2,7-DIONE SUBSTITUTE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRAL INFECTIONS
MA32351B1 (en) Aminodihydrothiazine derivatives as essential inhibitors for the treatment of Alzheimer's disease
MA35128B1 (en) Novel imidazole derivatives useful for the treatment of arthritis
MA37405A1 (en) Heterocyclyl compounds
MA35351B1 (en) Novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes.
MA40301A1 (en) Indolecarboxamide compounds useful as kinase inhibitors
EA201690094A1 (en) SYK INHIBITORS
MA42341A1 (en) Protein kinase inhibitor, process for its preparation and medical use
MA37866B1 (en) Aza-indazole or diaza-indazole derivatives for the treatment of pain
MA35016B1 (en) IMIDAZOPYRIDAZINES AS KINASE AKT INHIBITORS
MA35452B1 (en) 3-pyrimidin-4-yl-oxazolidin-2-ones as mutant idh inhibitors
MA35432B1 (en) Compound for the treatment and prophylaxis of respiratory syncytial virus disease
MA40225A (en) SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS
TN2015000347A1 (en) AZABENZIMIDAZOLES AS INHIBITORS OF PDE4 ISOENZYMES FOR THE TREATMENT OF CNS DISORDERS AND OTHER DISORDERS
UA98373C2 (en) Condensed heterocyclic compounds and use thereof as c-met inhibitors
EA201491012A1 (en) GLETAMINASE HETEROCYCLIC INHIBITORS
EA201500182A1 (en) 4-METHYL-2,3,5,9,9b-PENTAASACYCLOPENT [a] NAFTAIL
EA201492170A1 (en) NEW CYPRIDE N-PYRIDINYLAMIDES SUBSTITUTED AS A KINAZ INHIBITOR
EA201491747A1 (en) SUBSTITUTED PYRIDOPYRIMIDINE COMPOUNDS AND THEIR APPLICATION AS FLT3 INHIBITORS
EA201300250A1 (en) OXADIAZOL INHIBITORS OF LEUKOTRIEN PRODUCTION
TN2016000188A1 (en) 2,6-SUBSTITUTED PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS
MA31834B1 (en) 5 - [(3,3,3-TRIFLUORO-2-HYDROXY-1-ARYLPROPYL) AMINO] -1H-QUINOLIN-2-ONES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE AS ANTI-INFLAMMATORY
MA39048B1 (en) New inhibitors of dgat2
MA35886B1 (en) Benzylsulfanilamide derivatives used as -2 mogat inhibitors
NZ746906A (en) Oxaborole esters and uses thereof